Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases.

Area of Science:

• Neuroscience
• Stem Cell Biology
• Genetics

Background:

• Neurodegenerative disorders like Alzheimer's, Parkinson's, Huntington's, and ALS present significant therapeutic challenges.
• Human induced pluripotent stem cells (hiPSCs) offer a powerful tool for creating patient-specific cellular models of these complex diseases.
• Current hiPSC models recapitulate key disease phenotypes, providing valuable platforms for research.

Purpose of the Study:

• To review advancements in hiPSC-derived neuronal cell types for neurodegenerative disease modeling.
• To highlight the potential of hiPSC technology in developing complex in vitro models for Alzheimer's, Parkinson's, Huntington's, and ALS.
• To summarize therapeutic screening efforts using hiPSCs and discuss current limitations and future strategies.

Main Methods:

• Review of existing literature on hiPSC applications in neurodegenerative disease research.
• Analysis of phenotypic changes in various neuronal types relevant to Alzheimer's, Parkinson's, Huntington's, and ALS.
• Summary of low- and high-throughput screening experiments utilizing hiPSCs for drug development.

Main Results:

• hiPSC technology effectively recapitulates key disease phenotypes in patient-specific neurodegenerative models.
• Significant progress has been made in deriving various neuronal subtypes from hiPSCs for disease modeling.
• hiPSCs have been utilized in screening platforms for identifying potential therapeutics for neurodegenerative diseases.

Conclusions:

• hiPSC-derived neuronal models are crucial for understanding neurodegenerative disease mechanisms and developing targeted therapies.
• Further development of complex in vitro models using hiPSCs is essential for advancing Alzheimer's, Parkinson's, Huntington's, and ALS research.
• Addressing the limitations of hiPSC culture systems is key to maximizing their potential in neurodegenerative disease therapeutics development.